Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study

B.A. Sillars, Wendy Davis, I.B. Hirsch, Timothy Davis

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	757-765
Journal	Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics
Volume	12
DOIs	https://doi.org/10.1111/j.1463-1326.2010.01230.x
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{77acb9bca578431baa611bfbd37f37b9,

title = "Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study",

author = "B.A. Sillars and Wendy Davis and I.B. Hirsch and Timothy Davis",

year = "2010",

doi = "10.1111/j.1463-1326.2010.01230.x",

language = "English",

volume = "12",

pages = "757--765",

journal = "Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics",

issn = "1462-8902",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study

AU - Sillars, B.A.

AU - Davis, Wendy

AU - Hirsch, I.B.

AU - Davis, Timothy

PY - 2010

Y1 - 2010

U2 - 10.1111/j.1463-1326.2010.01230.x

DO - 10.1111/j.1463-1326.2010.01230.x

M3 - Article

C2 - 20649627

SN - 1462-8902

VL - 12

SP - 757

EP - 765

JO - Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics

JF - Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics

ER -